Stock Warrant
WARRANTErnexa Therapeutics Inc. Warrants
No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.
ERNAW is Ernexa Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.06.
Stock snapshot
| Price | $0.06 |
| Market cap | — |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About ERNAW
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.
Related non-dividend companies
Other non-dividend stocks investors research alongside ERNAW. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ERNAW's current stock price?
ERNAW (Ernexa Therapeutics Inc.) is currently trading at $0.06.
Does ERNAW pay a dividend?
ERNAW (Ernexa Therapeutics Inc.) does not currently pay a regular dividend.
Track ERNAW in DiviDrip
Add ERNAW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ERNAW and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.